﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Hamadan University of Medical Sciences</PublisherName>
      <JournalTitle>Avicenna Journal of Dental Research</JournalTitle>
      <Issn>2423-7582</Issn>
      <Volume>10</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2018</Year>
        <Month>03</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Comparison the Effect of Ciprofloxacin Versus Amoxicillin and Metronidazole as an Adjunctive Therapy to Full Mouth Scaling and Root Planing of Chronic Periodontitis</ArticleTitle>
    <FirstPage>11</FirstPage>
    <LastPage>15</LastPage>
    <ELocationID EIdType="doi">10.34172/ajdr.2018.03</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Janet</FirstName>
        <LastName>Moradi Haghgoo</LastName>
      </Author>
      <Author>
        <FirstName>Parviz</FirstName>
        <LastName>Torkzaban</LastName>
      </Author>
      <Author>
        <FirstName>Nazli</FirstName>
        <LastName>Rabienejad</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-2176-9786</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/ajdr.2018.03</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>06</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>02</Month>
        <Day>23</Day>
      </PubDate>
    </History>
    <Abstract>Background: So many people worldwide have chronic periodontitis. Chemotherapeutic agents can reduce host responses to bacterial pathogens and as a result reduce bone loss. Objectives: The aim of this study was to compare the effect of antibiotics such as amoxicillin and metronidazole (AMX+MTZ) with ciprofloxacin (CPF) as an adjunct to scaling and root planing (SRP) in pocket depth (PD) and clinical attachment loss (CAL) in patients with moderate to severe chronic periodontitis. Methods: In this randomized double-blinded placebo-controlled clinical trials, 45 patients with chronic moderate to severe periodontitis were randomly divided into 3 groups: the control group which received SRP plus placebo, the test 1 group which received SRP plus AMX+MTZ, and the test 2 group which received SRP plus CPF. PD and CAL were measured in each group at 3 time points (baseline, 1 month and 3 months after SRP). Statistical analysis was done using a paired t test and ANOVA. Results: Mean PD and CAL in the test groups were compared to the control group and no significant changes were found (P&lt;0.05). Most changes in PD and CAL were seen at one month after intervention. Better outcomes were seen in the test groups (test 2 better than test 1). Conclusions: AMX+MTZ or CPF as an adjunct to SRP had better outcomes but did not have any significant impact on reducing PD and CAL over one 1 and 3 months after treatment in patients with chronic periodontitis.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Amoxicillin</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Chronic periodontitis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Ciprofloxacin</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Clinical attachment loss</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Metronidazole</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Pocket depth</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>